Miranda Van Eck

10.8k total citations · 1 hit paper
182 papers, 8.4k citations indexed

About

Miranda Van Eck is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Miranda Van Eck has authored 182 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Surgery, 69 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Miranda Van Eck's work include Cholesterol and Lipid Metabolism (92 papers), Peroxisome Proliferator-Activated Receptors (48 papers) and Drug Transport and Resistance Mechanisms (40 papers). Miranda Van Eck is often cited by papers focused on Cholesterol and Lipid Metabolism (92 papers), Peroxisome Proliferator-Activated Receptors (48 papers) and Drug Transport and Resistance Mechanisms (40 papers). Miranda Van Eck collaborates with scholars based in Netherlands, United States and China. Miranda Van Eck's co-authors include Theo J.C. van Berkel, Menno Hoekstra, Ruud Out, Reeni B. Hildebrand, Illiana Meurs, J. Kar Kruijt, Johan Kuiper, Suzanne J.A. Korporaal, Ying Zhao and Patrick C.N. Rensen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Miranda Van Eck

181 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression

2019 347 citations Miranda Van Eck et al. profile →

Peers

Countries citing papers authored by Miranda Van Eck

Since Specialization

Citations

This map shows the geographic impact of Miranda Van Eck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Van Eck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Van Eck more than expected).

Fields of papers citing papers by Miranda Van Eck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miranda Van Eck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Van Eck. The network helps show where Miranda Van Eck may publish in the future.

Co-authorship network of co-authors of Miranda Van Eck

This figure shows the co-authorship network connecting the top 25 collaborators of Miranda Van Eck. A scholar is included among the top collaborators of Miranda Van Eck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miranda Van Eck. Miranda Van Eck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low‐density lipoprotein receptor knockout mice 2024 ·The Journal of Physiology ·Menno Hoekstra, (unknown), (unknown), (unknown), (unknown), Benjamin D. Sullivan, Tannin A. Schmidt, Gregory D. Jay, Miranda Van Eck	3
2	LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice 2024 ·Biomolecules ·Menno Hoekstra, (unknown), (unknown), (unknown), (unknown), Janine J. Geerling, Miranda Van Eck	1
3	Metyrapone Treatment Protects Low-Density Lipoprotein Receptor Knockout Mice against Hypercorticosteronemia Development without Changing Atherosclerosis Susceptibility 2023 ·Biomolecules ·Ronald J. van der Sluis, (unknown), (unknown), Miranda Van Eck, Menno Hoekstra	0
4	Apolipoprotein A1 deficiency in mice primes bone marrow stem cells for T cell lymphopoiesis 2021 ·Journal of Cell Science ·(unknown), Myrthe E. Reiche, (unknown), (unknown), (unknown), Frank H. Schaftenaar, (unknown), Esther Lutgens, Miranda Van Eck, Menno Hoekstra	7
5	Impact of bone marrow ATP-binding cassette transporter A1 deficiency on atherogenesis is independent of the presence of the low-density lipoprotein receptor 2021 ·Atherosclerosis ·(unknown), Ying Zhao, Laura Calpe‐Berdiel, Bart Lammers, Menno Hoekstra, Theo J.C. van Berkel, Miranda Van Eck	4
6	Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice 2018 ·Atherosclerosis ·(unknown), Menno Hoekstra, (unknown), Frank H. Schaftenaar, (unknown), (unknown), Suzanne J.A. Korporaal, Miranda Van Eck	5
7	Simvastatin treatment aggravates the glucocorticoid insufficiency associated with hypocholesterolemia in mice 2017 ·Atherosclerosis ·(unknown), Ronald J. van der Sluis, (unknown), Miranda Van Eck, Menno Hoekstra	10
8	HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export 2015 ·Circulation Research ·(unknown), Mi‐Jurng Kim, Liming Hou, Wilfried Le Goff, M. John Chapman, Miranda Van Eck, Linda K. Curtiss, John R. Burnett, Siân P. Cartland, Carmel M. Quinn, Maaike Kockx, Anatol Kontush, Kerry‐Anne Rye, Leonard Kritharides, Wendy Jessup	240
9	Human ATP–Binding Cassette G1 Controls Macrophage Lipoprotein Lipase Bioavailability and Promotes Foam Cell Formation 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), Michael W.T. Tanck, Ruud Out, Elise F. Villard, Bart Lammers, Laura Bouchareychas, Éric Frisdal, (unknown), Theo van Berkel, John J.P. Kastelein, Miranda Van Eck, J. Wouter Jukema, M. John Chapman, Geesje M. Dallinga‐Thie, Maryse Guérin, Wilfried Le Goff	32
10	Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice 2012 ·Atherosclerosis ·Laura Calpe‐Berdiel, Ying Zhao, Marjo de Graauw, Dan Ye, Peter J. van Santbrink, A. Mieke Mommaas, Amanda C. Foks, Martine Bot, Illiana Meurs, Johan Kuiper, (unknown), Miranda Van Eck, Kenneth D. Tew, Theo J.C. van Berkel	13
11	Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? 2012 ·Journal of Lipid Research ·(unknown), Miranda Van Eck	140
12	LCAT deficiency in mice is associated with a diminished adrenal glucocorticoid function 2012 ·Journal of Lipid Research ·Menno Hoekstra, Suzanne J.A. Korporaal, Ronald J. van der Sluis, Veronica Hirsch‐Reinshagen, Andrea E. Bochem, Cheryl L. Wellington, Theo J.C. van Berkel, Jan Albert Kuivenhoven, Miranda Van Eck	17
13	The Dynamics of Macrophage Infiltration into the Arterial Wall during Atherosclerotic Lesion Development in Low-Density Lipoprotein Receptor Knockout Mice 2011 ·American Journal Of Pathology ·Dan Ye, Ying Zhao, Reeni B. Hildebrand, Roshni R. Singaraja, Michael R. Hayden, Theo J.C. van Berkel, Miranda Van Eck	24
14	The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis 2011 ·Atherosclerosis ·Illiana Meurs, Bart Lammers, Ying Zhao, Ruud Out, Reeni B. Hildebrand, Menno Hoekstra, Theo J.C. van Berkel, Miranda Van Eck	60
15	The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice 2010 ·PLoS ONE ·Ivan Tancevski, Egon Demetz, Kathrin Eller, (unknown), Julia Hoefer, (unknown), Ursula Stanzl, Andreas Wehinger, (unknown), (unknown), Julia Huber, Wilfried Schgoer, Miranda Van Eck, Jonathan Vanhoutte, Catherine Fiévet, Frans Stellaard, Mats Rudling, Josef R. Patsch, Andreas Ritsch	43
16	Cyclosporin A Decreases Apolipoprotein E Secretion from Human Macrophages via a Protein Phosphatase 2B-dependent and ATP-binding Cassette Transporter A1 (ABCA1)-independent Pathway 2009 ·Journal of Biological Chemistry ·Maaike Kockx, (unknown), Mathew Traini, Katharina Gaus, Jason G. Kay, Sabine Wimmer-Kleikamp, Carles Rentero, John R. Burnett, Wilfried Le Goff, Miranda Van Eck, Jennifer L. Stow, Wendy Jessup, Leonard Kritharides	20
17	Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting 2008 ·Journal of Lipid Research ·Menno Hoekstra, Illiana Meurs, Mieke Koenders, Ruud Out, Reeni B. Hildebrand, J. Kar Kruijt, Miranda Van Eck, Theo J.C. van Berkel	73
18	Scavenger Receptor BI Plays a Role in Facilitating Chylomicron Metabolism 2004 ·Journal of Biological Chemistry ·Ruud Out, J. Kar Kruijt, Patrick C.N. Rensen, Reeni B. Hildebrand, Paul de Vos, Miranda Van Eck, Theo J.C. van Berkel	72
19	The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Jian Guo, Miranda Van Eck, Vivian de Waard, Nobuyo Maeda, G. Martin Benson, Pieter H.E. Groot, Theo J.C. van Berkel	9
20	Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. 1997 ·Journal of Clinical Investigation ·Patrick C.N. Rensen, Marijke van Oosten, (unknown), Miranda Van Eck, Johan Kuiper, (unknown)	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact